Demant Balance Sheet Health

Financial Health criteria checks 3/6

Demant has a total shareholder equity of DKK9.5B and total debt of DKK13.1B, which brings its debt-to-equity ratio to 137.5%. Its total assets and total liabilities are DKK32.4B and DKK22.9B respectively. Demant's EBIT is DKK4.0B making its interest coverage ratio 7.8. It has cash and short-term investments of DKK1.0B.

Key information

137.5%

Debt to equity ratio

DKK 13.10b

Debt

Interest coverage ratio	7.8x
Cash	DKK 1.05b
Equity	DKK 9.52b
Total liabilities	DKK 22.87b
Total assets	DKK 32.39b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: DEMANC's short term assets (DKK10.7B) exceed its short term liabilities (DKK7.5B).

Long Term Liabilities: DEMANC's short term assets (DKK10.7B) do not cover its long term liabilities (DKK15.4B).

Debt to Equity History and Analysis

Debt Level: DEMANC's net debt to equity ratio (126.5%) is considered high.

Reducing Debt: DEMANC's debt to equity ratio has increased from 95.3% to 137.5% over the past 5 years.

Debt Coverage: DEMANC's debt is well covered by operating cash flow (27.8%).

Interest Coverage: DEMANC's interest payments on its debt are well covered by EBIT (7.8x coverage).

Demant Balance Sheet Health

Financial Health criteria checks 3/6

Key information

Recent financial health updates

Recent updates

Demant A/S Appoints Anne-Karen Hunt as President of Diagnostics Business Area, Effective 1 November 2024

Demant A/S Announces Board Changes

Demant A/S Updates Earnings Guidance for the Year 2024

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Less than half of directors are independent

Demant A/S Provides Earnings Guidance for the Year 2024

Investor sentiment improves as stock rises 21%

Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S

Less than half of directors are independent

Demant A/S to Report Nine Months, 2024 Results on Nov 04, 2024

Less than half of directors are independent

Demant A/S Provides Earnings Guidance for the Year 2023

Less than half of directors are independent

Now 21% undervalued

Demant A/S Announces Executive Changes

Less than half of directors are independent

Investor sentiment improves as stock rises 16%

Less than half of directors are independent

Now 22% undervalued

Less than half of directors are independent

Less than half of directors are independent

Demant A/S to Report Fiscal Year 2022 Results on Feb 07, 2023

Less than half of directors are independent

Demant A/S Revised Earnings Guidance for the Full Year of 2022

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Demant A/S Revises Earnings Guidance for the Full Year 2022

Less than half of directors are independent

Less than half of directors are independent

Demant A/S (CPSE:DEMANT) acquired remaining 80% interest in ShengWang for CNY.

Less than half of directors are independent

Demant A/S Appoints Niels Wagner to the Board of Directors

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Demant A/S Announces Update on Voluntary Field Corrective Action

Less than half of directors are independent

Demant A/Sreiterated Guidance for the Year 2021

Less than half of directors are independent

Less than half of directors are independent

Demant A/S Updates Earnings Guidance for the Year 2021

Independent Director has left the company

Independent Director has left the company

New 90-day high: kr.263

Full year 2020 earnings released: EPS kr.4.68 (vs kr.6.00 in FY 2019)

Revenue beats expectations

Demant A/S Announces Executive Changes

New 90-day high: kr.237

Demant Launches New Flagship Hearing aids

New 90-day high: kr.235

Demant A/S, Annual General Meeting, Mar 05, 2021

Demant A/S Revises Earnings Guidance for the Second Half of Fiscal Year 2020

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies